Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Krystal Biotech (NASDAQ: KRYS) CEO reports new equity awards and tax share surrenders
Krystal Biotech’s CEO, Krish S. Krishnan, reported the vesting of restricted and performance stock units, which converted into common shares. He also received new equity awards, including stock options for 45,249 shares and 18,140 restricted stock units, both vesting over four years. Notably, shares were surrendered to the company for tax withholding purposes rather than being sold on the open market.